Virological Suppression Rate and Drug Resistance in Children and Adolescents Receiving Dolutegravir‐Containing Antiretroviral Therapy in Ndop Health District, Cameroon
Tropical Medicine & International Health · 2026-11 · 31 (11) · 1584-1591
DOI: 10.1111/tmi.70196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tropical Medicine & International Health, online erschienen am 07.07.2026. Verfasst von Precious Nkam Ache und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Parasitology, Faculty of Science, University of Bamenda, Bamenda, Cameroon. Hauptthemen laut MEDLINE: Heterocyclic Compounds, 3-Ring, HIV Infections, Oxazines, Drug Resistance, Viral. Die Arbeit nennt 23 Literaturangaben. Gefördert von: UNESCO-TWAS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objectives
This study aimed at evaluating the rate of virological suppression and profiles of HIV‐1 drug resistance in HIV‐positive children and adolescents taking Dolutegravir‐based antiretroviral therapy in the Ndop health district of Cameroon.
Methods
This hospital‐based, cross‐sectional study was carried out from February to May 2025. Children and adolescents (5–19 years) living with HIV‐1, who had been taking Dolutegravir‐based regimens for at least a year, were included in the study. Participants with virological failure (viral load > 1000 copies/mL) underwent HIV‐1 genotypic resistance testing (RNA extraction, cDNA synthesis, nested PCRs and Sanger sequencing) targeting the reverse transcriptase and integrase regions of the pol gene. Mutations were interpreted using the Stanford HIV drug resistance database.
Results
Out of 82 eligible participants receiving Tenofovir–Lamivudine–Dolutegravir (TLD) regimen, 75 (91.5%) achieved virological suppression (VL < 1000 copies/mL). Among 7 virally unsuppressed individuals, 5 (6.1%) were successfully genotyped. The major integrase resistance mutation G140GRS was detected in one participant (1/5; 20%). Univariate analysis to identify potential risk factors associated with drug resistance revealed no statistically significant associations. However, it was observed that major or accessory DRMs were more common in males, participants in secondary school and those taking antiretroviral drugs for a duration of 3–5 years.
Conclusions
The TLD regimen remains highly effective in viral suppression, with very low resistance rates observed. Targeted adherence support for high‐risk adolescents like those in secondary school is critical to preserve treatment efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Parasitology, Faculty of Science, University of Bamenda, Bamenda, Cameroon.
- TOZARD Research Laboratory, Bambili, Cameroon.
- District Hospital Ndop, Ndop, Cameroon.
ORCID-Profile: Herbert Afegenwi Mbunkah
Förderung
- UNESCO-TWAS
Zitieren
APA
Ache, P. N., Mbunkah, H. A., Mambi, W., Sama, B. A., & Anong, D. N. (2026). Virological Suppression Rate and Drug Resistance in Children and Adolescents Receiving Dolutegravir‐Containing Antiretroviral Therapy in Ndop Health District, Cameroon. Tropical Medicine & International Health, 31(11), 1584-1591. https://doi.org/10.1111/tmi.70196
Vancouver
Ache PN, Mbunkah HA, Mambi W, Sama BA, Anong DN. Virological Suppression Rate and Drug Resistance in Children and Adolescents Receiving Dolutegravir‐Containing Antiretroviral Therapy in Ndop Health District, Cameroon. Tropical Medicine & International Health. 2026;31(11):1584-1591. doi:10.1111/tmi.70196
BibTeX
@article{Ache2026,
author = {Ache, Precious Nkam and Mbunkah, Herbert Afegenwi and Mambi, Wijnand and Sama, Bella A and Anong, Damian Nota},
title = {Virological Suppression Rate and Drug Resistance in Children and Adolescents Receiving Dolutegravir‐Containing Antiretroviral Therapy in Ndop Health District, Cameroon},
journal = {Tropical Medicine & International Health},
year = {2026},
volume = {31},
number = {11},
pages = {1584--1591},
doi = {10.1111/tmi.70196}
}
EUVIMED